No evidence of genetic heterogeneity in Crouzon craniofacial dysostosis.

Abstract

Crouzon craniofacial dysostosis (CFD) is an autosomal dominant form of craniosynostosis characterized by an abnormal skull shape, with hypertelorism, prominent eyes and midfacial retrusion. Recently, a gene for CFD has been mapped to chromosome 10q25-q26 and mutations in exon B of the fibroblast growth factor receptor 2 (FGFR2) gene have been identified. Here, we report the mapping of a CFD gene to chromosome 10q by close linkage to probe AFMa197wb1 at locus D10 S1483 in six unrelated families of French ancestry (Zmax = 4.69 at theta = 0) and provide additional evidence of genetic homogeneity of this condition. In addition, we report a novel mutation in exon B of the FGFR2 gene (Cys 342 Trp) in familial CFD and describe recurrent mutations at codon 342 as a particularly frequent event in CFD. Since mutations in the extracellular domain of the FGFR2 gene are observed in a few clinically distinct craniosynostosis syndromes (CFD, Jackson-Weiss, Apert and Pfeiffer), the present study gives support to the variable clinical expression of FGFR2 mutations in humans.

• Authors: H W Ma, E Lajeunie, M Le Merrer, N de Parseval, F Serville, J Weissenbach, A Munnich, D Renier
• Journal: Human genetics (Hum Genet) Vol. 96 Issue 6 Pg. 731-5 (Dec 1995) ISSN: 0340-6717 [Print] Germany
• PMID: 8522336 (Publication Type: Journal Article)

Chemical References

• Codon
• Receptors, Fibroblast Growth Factor
• FGFR2 protein, human
• Receptor Protein-Tyrosine Kinases
• Receptor, Fibroblast Growth Factor, Type 2

Topics

• Chromosome Mapping
• Chromosomes, Human, Pair 10
• Codon (genetics)
• Craniofacial Dysostosis (genetics)
• Exons
• Family
• Female
• France
• Genes, Dominant
• Genetic Linkage
• Genotype
• Humans
• Male
• Pedigree
• Point Mutation
• Receptor Protein-Tyrosine Kinases (genetics)
• Receptor, Fibroblast Growth Factor, Type 2
• Receptors, Fibroblast Growth Factor (genetics)
• Recombination, Genetic